Showing results 4 to 11 of 11
< previous
| Preview | Issue Date | Title / Name | Author(s) | Type |
| 31-May-2023 | Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry. | Wen Lok, Sheau; Tung, Iris; Anton, Angelyn; Baron-Hay, Sally; De Boer, Richard H., et al | Conference Paper | |
| 2020 | Real world outcomes in elderly patients with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2021 | Real world outcomes in elderly women with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
 | 2020 | Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast Cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2021 | Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| Oct-2022 | Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda, et al | Journal Article | |
| 2020 | Real-world uptake of bone modifying agents in advanced breast cancer with bone metastases-Prospective data from a multi-site Australian registry | Wong, Vanessa; De Boer, Richard; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally, et al | Conference Paper | |
| 2021 | Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry | Wong, Vanessa; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq, et al | Journal Article | |
